Higher IgG index found in African Americans versus Caucasians with multiple sclerosis
- PMID: 17606883
- DOI: 10.1212/01.wnl.0000265057.79843.d9
Higher IgG index found in African Americans versus Caucasians with multiple sclerosis
Abstract
Background: African Americans (AAs) experience greater disability from multiple sclerosis (MS) compared with Caucasian Americans (CAs). Interethnic immunologic differences in MS and their relationship to disease-related disability have not been described.
Objective: To compare measures of CSF humoral immunity between AAs and CAs with MS.
Methods: Using a case-control design, all AA MS patients with CSF immune studies at the Washington University MS center were compared with randomly selected CAs with MS. Two CA controls were selected for every AA case. Immunoglobulin G (IgG) index and synthesis rates, oligoclonal band positivity, white blood cell count, and CSF protein were compared between groups. Survival analysis was conducted to compare times to ambulatory assistance.
Results: Sixty-six AA cases and 132 CA controls were identified. Measures of CSF humoral activity were all higher in the AA group. The mean IgG index of AAs was 1.35 (SD 0.62), and that of CAs was 1.05 (SD 0.55), for a mean difference of 0.30 (p = 0.001). The median IgG synthesis rate was also higher among AAs (13.55 vs 8.20 mg/day), for a median difference of 5.35 mg/day (p = 0.010). Survival analysis confirmed previous reports of earlier ambulatory assistance requirement among AAs. Despite differences in both humoral immune response and times to ambulatory assistance, Cox proportional hazards modeling did not show IgG index as predictive of earlier ambulatory assistance.
Conclusions: The CSF humoral immune response is more active among African Americans (AAs) than among Caucasian Americans (CAs) with multiple sclerosis. AAs also progress to ambulatory assistance earlier than CAs, but high immunoglobulin G index does not predict earlier progression to the disability endpoint.
Similar articles
-
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.Neurology. 2004 Dec 14;63(11):2039-45. doi: 10.1212/01.wnl.0000145762.60562.5d. Neurology. 2004. PMID: 15596747
-
CSF characteristics in early-onset multiple sclerosis.Neurology. 2004 Nov 23;63(10):1966-7. doi: 10.1212/01.wnl.0000144352.67102.bc. Neurology. 2004. PMID: 15557527
-
MRI correlates of disability in African-Americans with multiple sclerosis.PLoS One. 2012;7(8):e43061. doi: 10.1371/journal.pone.0043061. Epub 2012 Aug 10. PLoS One. 2012. PMID: 22900088 Free PMC article.
-
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.J Neuroimmunol. 2006 Nov;180(1-2):17-28. doi: 10.1016/j.jneuroim.2006.07.006. Epub 2006 Sep 1. J Neuroimmunol. 2006. PMID: 16945427 Review.
-
Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis.Adv Neurol. 2006;98:147-60. Adv Neurol. 2006. PMID: 16400832 Review. No abstract available.
Cited by
-
Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment.Brain Commun. 2023 Aug 14;5(4):fcad218. doi: 10.1093/braincomms/fcad218. eCollection 2023. Brain Commun. 2023. PMID: 37601407 Free PMC article.
-
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.Brain. 2015 Mar;138(Pt 3):632-43. doi: 10.1093/brain/awu405. Epub 2015 Jan 22. Brain. 2015. PMID: 25616667 Free PMC article.
-
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.Mult Scler Int. 2011;2011:246412. doi: 10.1155/2011/246412. Epub 2011 Jul 18. Mult Scler Int. 2011. Retraction in: Mult Scler Int. 2016;2016:8304273. doi: 10.1155/2016/8304273. PMID: 22096631 Free PMC article. Retracted.
-
A tale of race and B cells in multiple sclerosis.Nat Rev Neurol. 2024 Jan;20(1):5-6. doi: 10.1038/s41582-023-00907-x. Nat Rev Neurol. 2024. PMID: 37990136 No abstract available.
-
Black African and Latino/a identity correlates with increased plasmablasts in MS.Neurol Neuroimmunol Neuroinflamm. 2019 Oct 31;7(1):e634. doi: 10.1212/NXI.0000000000000634. Print 2020 Jan. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31672834 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical